Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?18.42
 
WKN: A2QQM0 / Symbol: MBRX / Name: Moleculin Biotech / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Moleculin Biotech Inc Stock

With 24 Sell predictions and only 3 Buy predictions Moleculin Biotech Inc is one of the least favorite stocks of our community.
However, we have a potential of 4290.24% for Moleculin Biotech Inc as the target price of 18 € is above the current price of 0.41 €.

Moleculin Biotech (Symbol: MBRX) is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing a broad range of innovative cancer treatments. With a diversified portfolio of drug candidates targeting difficult-to-treat cancers, including leukemia, lung, and pancreatic tumors, MBRX leverages cutting-edge scientific research and expertise to develop drugs that aim to provide improved patient outcomes. The company's innovative approach includes utilizing metabolic inhibitors, immune-globulin-like transcript 3 (ILT3) inhibitors, and STAT3 inhibitors as key weapons in the fight against cancer. As Moleculin Biotech advances its drug candidates through clinical trials, it holds the promise of bringing novel cancer therapies to market, potentially improving the lives of cancer patients globally.

Pros and Cons of Moleculin Biotech Inc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Moleculin Biotech Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Moleculin Biotech Inc - - - - - - -
Biotec Pharmacon ASA -1.180% -2.098% -3.448% -40.510% -41.667% -75.945% 430.303%
PharmAust Ltd. 8.780% -21.845% -42.908% 109.091% 30.894% 54.808% 373.529%
Celsion Corp. 2.310% 3.906% 5.556% 20.909% 123.529% -90.517% -94.960%

Comments

Moleculin Biotech, Inc. (NASDAQ: MBRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MBRX provided by MarketBeat
Show more

Moleculin Biotech, Inc. (NASDAQ: MBRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MBRX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 37.576
Change
Ends at 12.04.25

Moleculin Biotech, Inc. (NASDAQ: MBRX) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $40.00 price target on the stock.
Ratings data for MBRX provided by MarketBeat
Show more